Report cover image

Global Transdermal Drug Patches Market Report, History and Forecast 2017-2028

Publisher QYResearch Group
Published Dec 01, 2022
Length 138 Pages
SKU # QYR17563521

Description

Market Analysis and Insights: Global Transdermal Drug Patches Market

Due to the COVID-19 pandemic, the global Transdermal Drug Patches market size was value at US$ 6,680.25 million in 2021 and is forecast to be a readjusted size of US$ 7630.01 million by 2028 with a CAGR of 1.86% during the forecast period 2022-2028.

The global main manufacturers of Transdermal Drug Patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, and IBSA Group, etc. In 2021, the global six largest players have a share approximately 41.80% in terms of revenue.

The North America Transdermal Drug Patches market size was US$ 3,340.28 million in 2021, while China was about US$ 288.23 million. The proportion of the China was 4.31% in 2021 and it is predicted that the share will reach 8.89% in 2028, trailing a CAGR of 12.34% through the analysis period.

Fully considering the economic change by the COVID-19, Methyl Salicylate-based Patch accounting for 13.17% of the Transdermal Drug Patches global market in 2021, is projected to value US$ 800.46 million by 2028, growing at a revised -0.91% CAGR from 2022 to 2028. While Rx Channel segment is altered to an 1.77% CAGR throughout this forecast period and will hold a share about 93.49% in 2028.

Global Transdermal Drug Patches Scope and Market Size

The global Transdermal Drug Patches market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.

Segment by Type

Methyl Salicylate-based Patch

Rivastigmine Transdermal Patch

Fentanyl Transdermal Patch

Lidocaine Patch

Diclofenac Patch

Nicotine Transdermal Patch

Others

Segment by Application

Rx Channel

OTC Channel

By Company

Hisamitsu Pharmaceutical

Johnson & Johnson

Mylan

UCB Pharma

Novartis

Teva Pharmaceutical

Beijing Tide Pharmaceutical

Chattem

Nitto Denko

Grünenthal

Mundipharma

GSK

Luye Pharma Group

Bayer

IBSA Group

Dr Reddy’s Laboratories

By Region

North America

U.S.

Canada

Mexico

Asia-Pacific

China

Japan

South Korea

India

Australia

SEA

Europe

Germany

France

U.K.

Italy

Spain

South America

Brazil

Argentina

Middle East & Africa

Saudi Arabia

UAE

Turkey

South Africa

Table of Contents

138 Pages
1 TRANSDERMAL DRUG PATCHES MARKET OVERVIEW
1.1 TRANSDERMAL DRUG PATCHES PRODUCT OVERVIEW
1.2 TRANSDERMAL DRUG PATCHES MARKET SEGMENT BY TYPE
1.2.1 METHYL SALICYLATE-BASED PATCH
1.2.2 RIVASTIGMINE TRANSDERMAL PATCH
1.2.3 FENTANYL TRANSDERMAL PATCH
1.2.4 LIDOCAINE PATCH
1.2.5 DICLOFENAC PATCH
1.2.6 NICOTINE TRANSDERMAL PATCH
1.3 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE BY TYPE
1.3.1 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE OVERVIEW BY TYPE (2017-2028)
1.3.2 GLOBAL TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022)
1.3.3 GLOBAL TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY TYPE (2023-2028)
1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE
1.4.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
1.4.2 EUROPE TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
1.4.3 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
1.4.4 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
1.4.5 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY TYPE (2017-2022)
2 TRANSDERMAL DRUG PATCHES MARKET COMPETITION BY COMPANY
2.1 GLOBAL TOP PLAYERS BY TRANSDERMAL DRUG PATCHES SALES (2017-2022)
2.2 GLOBAL TOP PLAYERS BY TRANSDERMAL DRUG PATCHES REVENUE (2017-2022)
2.3 GLOBAL TOP PLAYERS BY TRANSDERMAL DRUG PATCHES PRICE (2017-2022)
2.4 GLOBAL TOP MANUFACTURERS TRANSDERMAL DRUG PATCHES MANUFACTURING BASE DISTRIBUTION, SALES AREA, PRODUCT TYPE
2.5 TRANSDERMAL DRUG PATCHES MARKET COMPETITIVE SITUATION AND TRENDS
2.5.1 TRANSDERMAL DRUG PATCHES MARKET CONCENTRATION RATE
2.5.2 GLOBAL 5 LARGEST MANUFACTURERS BY TRANSDERMAL DRUG PATCHES REVENUE IN 2021
2.6 GLOBAL TOP MANUFACTURERS BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) & (BASED ON THE REVENUE IN TRANSDERMAL DRUG PATCHES AS OF 2021)
2.7 KEY MANUFACTURERS TRANSDERMAL DRUG PATCHES PRODUCT OFFERED
2.8 MERGERS & ACQUISITIONS, EXPANSION
3 TRANSDERMAL DRUG PATCHES STATUS AND OUTLOOK BY REGION
3.1 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE AND CAGR BY REGION: 2017 VS 2022 VS 2028
3.2 GLOBAL TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY REGION
3.2.1 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2017-2022)
3.2.2 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2017-2022)
3.2.3 GLOBAL TRANSDERMAL DRUG PATCHES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2017-2022)
3.3 GLOBAL TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY REGION
3.3.1 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2023-2028)
3.3.2 GLOBAL TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2023-2028)
3.3.3 GLOBAL TRANSDERMAL DRUG PATCHES SALES (VOLUME & VALUE), PRICE AND GROSS MARGIN (2023-2028)
4 TRANSDERMAL DRUG PATCHES BY APPLICATION
4.1 TRANSDERMAL DRUG PATCHES MARKET SEGMENT BY APPLICATION
4.1.1 RX CHANNEL
4.1.2 OTC CHANNEL
4.2 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE BY APPLICATION
4.2.1 GLOBAL TRANSDERMAL DRUG PATCHES MARKET SIZE OVERVIEW BY APPLICATION (2017-2028)
4.2.2 GLOBAL TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022)
4.2.3 GLOBAL TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
4.3 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION
4.3.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
4.3.2 EUROPE TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
4.3.3 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
4.3.4 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
4.3.5 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES BREAKDOWN BY APPLICATION (2017-2022)
5 NORTH AMERICA TRANSDERMAL DRUG PATCHES BY COUNTRY
5.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY
5.1.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022)
5.1.2 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022)
5.2 NORTH AMERICA TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY
5.2.1 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028)
5.2.2 NORTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028)
6 EUROPE TRANSDERMAL DRUG PATCHES BY COUNTRY
6.1 EUROPE TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY
6.1.1 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022)
6.1.2 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022)
6.2 EUROPE TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY
6.2.1 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028)
6.2.2 EUROPE TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028)
7 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES BY REGION
7.1 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY REGION
7.1.1 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2017-2022)
7.1.2 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2017-2022)
7.2 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY REGION
7.2.1 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY REGION (2023-2028)
7.2.2 ASIA-PACIFIC TRANSDERMAL DRUG PATCHES SALES IN VALUE BY REGION (2023-2028)
8 SOUTH AMERICA TRANSDERMAL DRUG PATCHES BY COUNTRY
8.1 SOUTH AMERICA TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY
8.1.1 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022)
8.1.2 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022)
8.2 SOUTH AMERICA TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY
8.2.1 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028)
8.2.2 SOUTH AMERICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028)
9 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES BY COUNTRY
9.1 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES HISTORIC MARKET SIZE BY COUNTRY
9.1.1 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2017-2022)
9.1.2 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2017-2022)
9.2 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES FORECASTED MARKET SIZE BY COUNTRY
9.2.1 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VOLUME BY COUNTRY (2023-2028)
9.2.2 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG PATCHES SALES IN VALUE BY COUNTRY (2023-2028)
10 COMPANY PROFILES AND KEY FIGURES IN TRANSDERMAL DRUG PATCHES BUSINESS
10.1 HISAMITSU PHARMACEUTICAL
10.1.1 HISAMITSU PHARMACEUTICAL CORPORATION INFORMATION
10.1.2 HISAMITSU PHARMACEUTICAL INTRODUCTION AND BUSINESS OVERVIEW
10.1.3 HISAMITSU PHARMACEUTICAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.1.4 HISAMITSU PHARMACEUTICAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.2 JOHNSON & JOHNSON
10.2.1 JOHNSON & JOHNSON CORPORATION INFORMATION
10.2.2 JOHNSON & JOHNSON INTRODUCTION AND BUSINESS OVERVIEW
10.2.3 JOHNSON & JOHNSON TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.2.4 JOHNSON & JOHNSON TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.3 MYLAN
10.3.1 MYLAN CORPORATION INFORMATION
10.3.2 MYLAN INTRODUCTION AND BUSINESS OVERVIEW
10.3.3 MYLAN TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.3.4 MYLAN TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.4 UCB PHARMA
10.4.1 UCB PHARMA CORPORATION INFORMATION
10.4.2 UCB PHARMA INTRODUCTION AND BUSINESS OVERVIEW
10.4.3 UCB PHARMA TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.4.4 UCB PHARMA TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.5 NOVARTIS
10.5.1 NOVARTIS CORPORATION INFORMATION
10.5.2 NOVARTIS INTRODUCTION AND BUSINESS OVERVIEW
10.5.3 NOVARTIS TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.5.4 NOVARTIS TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.6 TEVA PHARMACEUTICAL
10.6.1 TEVA PHARMACEUTICAL CORPORATION INFORMATION
10.6.2 TEVA PHARMACEUTICAL INTRODUCTION AND BUSINESS OVERVIEW
10.6.3 TEVA PHARMACEUTICAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.6.4 TEVA PHARMACEUTICAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.7 BEIJING TIDE PHARMACEUTICAL
10.7.1 BEIJING TIDE PHARMACEUTICAL CORPORATION INFORMATION
10.7.2 BEIJING TIDE PHARMACEUTICAL INTRODUCTION AND BUSINESS OVERVIEW
10.7.3 BEIJING TIDE PHARMACEUTICAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.7.4 BEIJING TIDE PHARMACEUTICAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.8 CHATTEM
10.8.1 CHATTEM CORPORATION INFORMATION
10.8.2 CHATTEM INTRODUCTION AND BUSINESS OVERVIEW
10.8.3 CHATTEM TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.8.4 CHATTEM TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.9 NITTO DENKO
10.9.1 NITTO DENKO CORPORATION INFORMATION
10.9.2 NITTO DENKO INTRODUCTION AND BUSINESS OVERVIEW
10.9.3 NITTO DENKO TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.9.4 NITTO DENKO TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.10 GRÜNENTHAL
10.10.1 GRÜNENTHAL CORPORATION INFORMATION
10.10.2 GRÜNENTHAL INTRODUCTION AND BUSINESS OVERVIEW
10.10.3 GRÜNENTHAL TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.10.4 GRÜNENTHAL TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.11 MUNDIPHARMA
10.11.1 MUNDIPHARMA CORPORATION INFORMATION
10.11.2 MUNDIPHARMA INTRODUCTION AND BUSINESS OVERVIEW
10.11.3 MUNDIPHARMA TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.11.4 MUNDIPHARMA TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.12 GSK
10.12.1 GSK CORPORATION INFORMATION
10.12.2 GSK INTRODUCTION AND BUSINESS OVERVIEW
10.12.3 GSK TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.12.4 GSK TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.13 LUYE PHARMA GROUP
10.13.1 LUYE PHARMA GROUP CORPORATION INFORMATION
10.13.2 LUYE PHARMA GROUP INTRODUCTION AND BUSINESS OVERVIEW
10.13.3 LUYE PHARMA GROUP TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.13.4 LUYE PHARMA GROUP TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.14 BAYER
10.14.1 BAYER CORPORATION INFORMATION
10.14.2 BAYER INTRODUCTION AND BUSINESS OVERVIEW
10.14.3 BAYER TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.14.4 BAYER TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.15 IBSA GROUP
10.15.1 IBSA GROUP CORPORATION INFORMATION
10.15.2 IBSA GROUP INTRODUCTION AND BUSINESS OVERVIEW
10.15.3 IBSA GROUP TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.15.4 IBSA GROUP TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
10.16 DR REDDY’S LABORATORIES
10.16.1 DR REDDY’S LABORATORIES CORPORATION INFORMATION
10.16.2 DR REDDY’S LABORATORIES INTRODUCTION AND BUSINESS OVERVIEW
10.16.3 DR REDDY’S LABORATORIES TRANSDERMAL DRUG PATCHES SALES, REVENUE AND GROSS MARGIN (2017-2022)
10.16.4 DR REDDY’S LABORATORIES TRANSDERMAL DRUG PATCHES PRODUCTS OFFERED
11 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
11.1 TRANSDERMAL DRUG PATCHES KEY RAW MATERIALS
11.1.1 KEY RAW MATERIALS
11.1.2 RAW MATERIALS KEY SUPPLIERS
11.2 MANUFACTURING COST STRUCTURE
11.2.1 RAW MATERIALS
11.2.2 LABOR COST
11.2.3 MANUFACTURING EXPENSES
11.3 TRANSDERMAL DRUG PATCHES INDUSTRIAL CHAIN ANALYSIS
11.4 TRANSDERMAL DRUG PATCHES MARKET DYNAMICS
11.4.1 TRANSDERMAL DRUG PATCHES INDUSTRY TRENDS
11.4.2 TRANSDERMAL DRUG PATCHES MARKET DRIVERS
11.4.3 TRANSDERMAL DRUG PATCHES MARKET CHALLENGES
11.4.4 TRANSDERMAL DRUG PATCHES MARKET RESTRAINTS
12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS
12.1 SALES CHANNEL
12.2 TRANSDERMAL DRUG PATCHES DISTRIBUTORS
12.3 TRANSDERMAL DRUG PATCHES DOWNSTREAM CUSTOMERS
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 RESEARCH METHODOLOGY
14.1.1 METHODOLOGY/RESEARCH APPROACH
14.1.2 DATA SOURCE
14.2 AUTHOR DETAILS
14.3 DISCLAIMER
List of Tables
Table 1. Global Transdermal Drug Patches Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 2. Global Transdermal Drug Patches Sales by Type (2017-2022) & (M Pieces)
Table 3. Global Transdermal Drug Patches Sales Market Share in Volume by Type (2017-2022)
Table 4. Global Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
Table 5. Global Transdermal Drug Patches Sales Market Share in Value by Type (2017-2022)
Table 6. Global Transdermal Drug Patches Price by Type (2017-2022) & (USD/Piece)
Table 7. Global Transdermal Drug Patches Sales by Type (2023-2028) & (M Pieces)
Table 8. Global Transdermal Drug Patches Sales Market Share in Volume by Type (2023-2028)
Table 9. Global Transdermal Drug Patches Sales by Type (2023-2028) & (US$ Million)
Table 10. Global Transdermal Drug Patches Sales Market Share in Value by Type (2023-2028)
Table 11. Global Transdermal Drug Patches Price by Type (2023-2028) & (USD/Piece)
Table 12. North America Transdermal Drug Patches Sales by Type (2017-2022) & (M Pieces)
Table 13. North America Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
Table 14. Europe Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022)
Table 15. Europe Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
Table 16. Asia-Pacific Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022)
Table 17. Asia-Pacific Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
Table 18. South America Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022)
Table 19. South America Transdermal Drug Patches Sales by Type (2017-2022) & (US$ Million)
Table 20. Middle East and Africa Transdermal Drug Patches Sales (M Pieces) by Type (2017-2022)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us